Understanding how the eye can heal itself from damage
Elucidating the Molecular Underpinnings of Endogenous RPE Regeneration
['FUNDING_R01'] · UNIVERSITY OF TEXAS AT AUSTIN · NIH-11070670
This study is looking into how we can help eye cells that are important for vision heal themselves naturally, which could lead to new treatments for people with age-related macular degeneration and other eye conditions.
Quick facts
| Phase | ['FUNDING_R01'] |
|---|---|
| Study type | Nih_funding |
| Sex | All |
| Sponsor | UNIVERSITY OF TEXAS AT AUSTIN (nih funded) |
| Locations | 1 site (AUSTIN, UNITED STATES) |
| Trial ID | NIH-11070670 on ClinicalTrials.gov |
What this research studies
This research investigates the mechanisms behind the regeneration of retinal pigment epithelium (RPE) cells, which are crucial for vision and often damaged in age-related macular degeneration (AMD). The team aims to uncover how these cells can be stimulated to regenerate naturally, rather than relying solely on stem cell transplants. By studying the molecular and cellular processes involved in RPE regeneration, the research seeks to identify potential therapeutic strategies that could enhance the eye's ability to heal itself. This could lead to new treatments for patients suffering from vision loss due to AMD and other retinal diseases.
Who could benefit from this research
Good fit: Ideal candidates for this research are individuals experiencing age-related macular degeneration or other retinal diseases that affect the retinal pigment epithelium.
Not a fit: Patients with retinal conditions unrelated to RPE degeneration may not benefit from this research.
Why it matters
Potential benefit: If successful, this research could lead to innovative therapies that restore vision by promoting the eye's natural healing processes.
How similar studies have performed: While the approach of stimulating endogenous regeneration is gaining interest, it remains a relatively novel area of research with limited prior success.
Where this research is happening
AUSTIN, UNITED STATES
- UNIVERSITY OF TEXAS AT AUSTIN — AUSTIN, UNITED STATES (ACTIVE)
Researchers
- Principal investigator: GROSS, JEFFREY — UNIVERSITY OF TEXAS AT AUSTIN
- Study coordinator: GROSS, JEFFREY
About this research
- This is an active NIH-funded research project — typically early-stage science, not a clinical trial accepting patient enrollment.
- Some NIH-funded labs run parallel clinical studies or seek volunteers for related work. To check, contact the principal investigator or institution listed above.
- For full project details, budget, and progress reports, visit the official NIH RePORTER page below.
Conditions: age related macular disease